vs

Side-by-side financial comparison of Core Laboratories Inc. (CLB) and InvenTrust Properties Corp. (IVT). Click either name above to swap in a different company.

Core Laboratories Inc. is the larger business by last-quarter revenue ($121.8M vs $77.4M, roughly 1.6× InvenTrust Properties Corp.). Core Laboratories Inc. runs the higher net margin — 4.2% vs 3.4%, a 0.8% gap on every dollar of revenue. On growth, InvenTrust Properties Corp. posted the faster year-over-year revenue change (8.6% vs -1.4%). InvenTrust Properties Corp. produced more free cash flow last quarter ($110.9M vs $517.0K). Over the past eight quarters, InvenTrust Properties Corp.'s revenue compounded faster (7.6% CAGR vs -3.4%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

InvenTrust Properties Corp. is a real estate investment trust that invests in shopping malls. As of December 31, 2024, the company owned interests in 68 properties comprising 11.0 million square feet.

CLB vs IVT — Head-to-Head

Bigger by revenue
CLB
CLB
1.6× larger
CLB
$121.8M
$77.4M
IVT
Growing faster (revenue YoY)
IVT
IVT
+10.1% gap
IVT
8.6%
-1.4%
CLB
Higher net margin
CLB
CLB
0.8% more per $
CLB
4.2%
3.4%
IVT
More free cash flow
IVT
IVT
$110.4M more FCF
IVT
$110.9M
$517.0K
CLB
Faster 2-yr revenue CAGR
IVT
IVT
Annualised
IVT
7.6%
-3.4%
CLB

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLB
CLB
IVT
IVT
Revenue
$121.8M
$77.4M
Net Profit
$5.1M
$2.7M
Gross Margin
Operating Margin
1.5%
-11.0%
Net Margin
4.2%
3.4%
Revenue YoY
-1.4%
8.6%
Net Profit YoY
-72.8%
EPS (diluted)
$0.11
$0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLB
CLB
IVT
IVT
Q1 26
$121.8M
Q4 25
$138.3M
$77.4M
Q3 25
$134.5M
$74.5M
Q2 25
$130.2M
$73.6M
Q1 25
$123.6M
$73.8M
Q4 24
$129.2M
$71.2M
Q3 24
$134.4M
$68.5M
Q2 24
$130.6M
$67.4M
Net Profit
CLB
CLB
IVT
IVT
Q1 26
$5.1M
Q4 25
$4.9M
$2.7M
Q3 25
$14.2M
$6.0M
Q2 25
$10.6M
$95.9M
Q1 25
$-154.0K
$6.8M
Q4 24
$7.4M
$9.8M
Q3 24
$11.7M
$-539.0K
Q2 24
$9.0M
$1.5M
Gross Margin
CLB
CLB
IVT
IVT
Q1 26
Q4 25
20.8%
Q3 25
22.0%
Q2 25
20.3%
Q1 25
19.5%
Q4 24
17.8%
Q3 24
20.5%
Q2 24
21.2%
Operating Margin
CLB
CLB
IVT
IVT
Q1 26
1.5%
Q4 25
11.5%
-11.0%
Q3 25
15.6%
-9.8%
Q2 25
11.7%
Q1 25
3.6%
-10.5%
Q4 24
11.0%
-3.6%
Q3 24
14.7%
-18.7%
Q2 24
12.3%
-13.6%
Net Margin
CLB
CLB
IVT
IVT
Q1 26
4.2%
Q4 25
3.6%
3.4%
Q3 25
10.6%
8.1%
Q2 25
8.2%
130.4%
Q1 25
-0.1%
9.2%
Q4 24
5.7%
13.8%
Q3 24
8.7%
-0.8%
Q2 24
6.9%
2.2%
EPS (diluted)
CLB
CLB
IVT
IVT
Q1 26
$0.11
Q4 25
$0.11
$0.02
Q3 25
$0.30
$0.08
Q2 25
$0.22
$1.23
Q1 25
$0.00
$0.09
Q4 24
$0.15
$0.14
Q3 24
$0.25
$-0.01
Q2 24
$0.19
$0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLB
CLB
IVT
IVT
Cash + ST InvestmentsLiquidity on hand
$22.8M
Total DebtLower is stronger
$825.9M
Stockholders' EquityBook value
$275.1M
$1.8B
Total Assets
$587.7M
$2.8B
Debt / EquityLower = less leverage
0.46×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLB
CLB
IVT
IVT
Q1 26
$22.8M
Q4 25
$22.7M
Q3 25
$25.6M
Q2 25
$31.2M
Q1 25
$22.1M
Q4 24
$19.2M
Q3 24
$21.5M
Q2 24
$17.7M
Total Debt
CLB
CLB
IVT
IVT
Q1 26
Q4 25
$110.3M
$825.9M
Q3 25
$114.1M
$764.6M
Q2 25
$124.6M
$746.3M
Q1 25
$124.4M
$740.7M
Q4 24
$126.1M
$740.4M
Q3 24
$139.9M
$740.1M
Q2 24
$147.6M
$812.2M
Stockholders' Equity
CLB
CLB
IVT
IVT
Q1 26
$275.1M
Q4 25
$266.0M
$1.8B
Q3 25
$271.3M
$1.8B
Q2 25
$261.3M
$1.8B
Q1 25
$253.4M
$1.7B
Q4 24
$246.6M
$1.8B
Q3 24
$250.7M
$1.8B
Q2 24
$240.3M
$1.5B
Total Assets
CLB
CLB
IVT
IVT
Q1 26
$587.7M
Q4 25
$584.0M
$2.8B
Q3 25
$591.4M
$2.7B
Q2 25
$602.1M
$2.7B
Q1 25
$591.5M
$2.6B
Q4 24
$585.1M
$2.6B
Q3 24
$600.5M
$2.6B
Q2 24
$597.8M
$2.5B
Debt / Equity
CLB
CLB
IVT
IVT
Q1 26
Q4 25
0.41×
0.46×
Q3 25
0.42×
0.42×
Q2 25
0.48×
0.41×
Q1 25
0.49×
0.42×
Q4 24
0.51×
0.42×
Q3 24
0.56×
0.42×
Q2 24
0.61×
0.53×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLB
CLB
IVT
IVT
Operating Cash FlowLast quarter
$4.0M
$155.4M
Free Cash FlowOCF − Capex
$517.0K
$110.9M
FCF MarginFCF / Revenue
0.4%
143.3%
Capex IntensityCapex / Revenue
57.5%
Cash ConversionOCF / Net Profit
0.77×
58.41×
TTM Free Cash FlowTrailing 4 quarters
$22.5M
$193.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLB
CLB
IVT
IVT
Q1 26
$4.0M
Q4 25
$7.9M
$155.4M
Q3 25
$8.5M
$43.8M
Q2 25
$13.9M
$48.7M
Q1 25
$6.7M
$20.2M
Q4 24
$20.6M
$136.9M
Q3 24
$13.1M
$38.4M
Q2 24
$17.1M
$46.7M
Free Cash Flow
CLB
CLB
IVT
IVT
Q1 26
$517.0K
Q4 25
$5.0M
$110.9M
Q3 25
$6.5M
$31.4M
Q2 25
$10.4M
$38.0M
Q1 25
$3.9M
$12.8M
Q4 24
$17.4M
$100.8M
Q3 24
$10.4M
$29.3M
Q2 24
$14.3M
$37.2M
FCF Margin
CLB
CLB
IVT
IVT
Q1 26
0.4%
Q4 25
3.6%
143.3%
Q3 25
4.8%
42.2%
Q2 25
8.0%
51.6%
Q1 25
3.1%
17.4%
Q4 24
13.4%
141.5%
Q3 24
7.7%
42.8%
Q2 24
10.9%
55.2%
Capex Intensity
CLB
CLB
IVT
IVT
Q1 26
Q4 25
2.1%
57.5%
Q3 25
1.5%
16.7%
Q2 25
2.7%
14.6%
Q1 25
2.3%
10.0%
Q4 24
2.5%
50.7%
Q3 24
2.0%
13.3%
Q2 24
2.2%
14.0%
Cash Conversion
CLB
CLB
IVT
IVT
Q1 26
0.77×
Q4 25
1.61×
58.41×
Q3 25
0.60×
7.27×
Q2 25
1.31×
0.51×
Q1 25
2.97×
Q4 24
2.78×
13.97×
Q3 24
1.12×
Q2 24
1.90×
31.15×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons